Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026

Impact · against what's priced in

Talphera is hosting a virtual event to present the clinical rationale and investigator perspectives for Niyad in CRRT. While the event creates a short-term catalyst for visibility, the underlying medical need and the drug's established use in Asian markets are foundational elements of the product's value proposition.

TLPH+0.20

No priced-in read yet